I am a highly experienced reporter and editor covering the integration of genomics in routine healthcare for 20 years. For most of that time, I have worked at GenomeWeb, where I started out writing about genetic tests that predicted if a person would respond to drugs. Over the years, my beat evolved to encompass the entire healthcare ecosystem surrounding genomic medicine and the economic, regulatory, reimbursement, legal, and ethical challenges raised by this new field.
In 2019, I used my years-long reporting experience to design and launch a sister news publication under the GenomeWeb banner, called Precision Oncology News, which in 2023, I expanded to all diseases areas and rebranded as Precision Medicine Online. I'm responsible for guiding the publication's editorial mission, leading a team of reporters, and running daily operations.
Under my direction, our editorial mission is not just to cover new genomics advances in medicine, but also investigate why these new drugs and tests aren't reaching patients and how they might exacerbate existing healthcare disparities. I have developed surveys, recurring columns, and webinars through which we report on precision medicine's successes and investigate its shortcomings. I also organize an annual conference on precision oncology, speak at meetings on precision medicine topics and on journalism, and take on several big features or investigative stories every year in my areas of expertise.
In 2019, I used my years-long reporting experience to design and launch a sister news publication under the GenomeWeb banner, called Precision Oncology News, which in 2023, I expanded to all diseases areas and rebranded as Precision Medicine Online. I'm responsible for guiding the publication's editorial mission, leading a team of reporters, and running daily operations.
Under my direction, our editorial mission is not just to cover new genomics advances in medicine, but also investigate why these new drugs and tests aren't reaching patients and how they might exacerbate existing healthcare disparities. I have developed surveys, recurring columns, and webinars through which we report on precision medicine's successes and investigate its shortcomings. I also organize an annual conference on precision oncology, speak at meetings on precision medicine topics and on journalism, and take on several big features or investigative stories every year in my areas of expertise.